vs
HERITAGE FINANCIAL CORP（HFWA）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是HERITAGE FINANCIAL CORP的1.1倍（$69.8M vs $66.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 33.5%，领先350.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 16.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 16.8%）
总部位于美国华盛顿州的区域性金融控股公司，面向太平洋西北地区的当地社群提供服务，核心业务涵盖商业与零售银行服务，包含存款产品、中小企业贷款、住房抵押贷款、个人信贷及财富管理解决方案，核心客群为中小微企业及个人客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HFWA vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$66.3M
营收增速更快
RIGL
高出4.9%
16.3%
净利率更高
RIGL
高出350.5%
33.5%
两年增速更快
RIGL
近两年复合增速
16.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.3M | $69.8M |
| 净利润 | $22.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 38.7% | 33.2% |
| 净利率 | 33.5% | 384.0% |
| 营收同比 | 16.3% | 21.2% |
| 净利润同比 | 86.4% | 1769.2% |
| 每股收益（稀释后） | $0.65 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HFWARIGL
| Q4 25 | $66.3M | $69.8M | ||
| Q3 25 | $65.7M | $69.5M | ||
| Q2 25 | $56.5M | $101.7M | ||
| Q1 25 | $57.6M | $53.3M | ||
| Q4 24 | $57.1M | $57.6M | ||
| Q3 24 | $54.8M | $55.3M | ||
| Q2 24 | $56.4M | $36.8M | ||
| Q1 24 | $48.6M | $29.5M |
净利润HFWARIGL
| Q4 25 | $22.2M | $268.1M | ||
| Q3 25 | $19.2M | $27.9M | ||
| Q2 25 | $12.2M | $59.6M | ||
| Q1 25 | $13.9M | $11.4M | ||
| Q4 24 | $11.9M | $14.3M | ||
| Q3 24 | $11.4M | $12.4M | ||
| Q2 24 | $14.2M | $-1.0M | ||
| Q1 24 | $5.7M | $-8.2M |
毛利率HFWARIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率HFWARIGL
| Q4 25 | 38.7% | 33.2% | ||
| Q3 25 | 34.0% | 40.9% | ||
| Q2 25 | 25.6% | 60.1% | ||
| Q1 25 | 28.1% | 23.9% | ||
| Q4 24 | 28.6% | 28.9% | ||
| Q3 24 | 23.8% | 25.4% | ||
| Q2 24 | 28.4% | 1.2% | ||
| Q1 24 | 14.1% | -23.6% |
净利率HFWARIGL
| Q4 25 | 33.5% | 384.0% | ||
| Q3 25 | 29.2% | 40.2% | ||
| Q2 25 | 21.6% | 58.6% | ||
| Q1 25 | 24.2% | 21.5% | ||
| Q4 24 | 20.9% | 24.9% | ||
| Q3 24 | 20.8% | 22.5% | ||
| Q2 24 | 25.1% | -2.8% | ||
| Q1 24 | 11.8% | -27.9% |
每股收益（稀释后）HFWARIGL
| Q4 25 | $0.65 | $14.11 | ||
| Q3 25 | $0.55 | $1.46 | ||
| Q2 25 | $0.36 | $3.28 | ||
| Q1 25 | $0.40 | $0.63 | ||
| Q4 24 | $0.34 | $0.82 | ||
| Q3 24 | $0.33 | $0.70 | ||
| Q2 24 | $0.41 | $-0.06 | ||
| Q1 24 | $0.16 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $233.1M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $921.5M | $391.5M |
| 总资产 | $7.0B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HFWARIGL
| Q4 25 | $233.1M | $155.0M | ||
| Q3 25 | $245.5M | $137.1M | ||
| Q2 25 | $254.1M | $108.4M | ||
| Q1 25 | $248.7M | $77.1M | ||
| Q4 24 | $117.1M | $77.3M | ||
| Q3 24 | $175.6M | $61.1M | ||
| Q2 24 | $113.8M | $49.1M | ||
| Q1 24 | $189.6M | $49.5M |
总债务HFWARIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益HFWARIGL
| Q4 25 | $921.5M | $391.5M | ||
| Q3 25 | $904.1M | $117.6M | ||
| Q2 25 | $888.2M | $81.9M | ||
| Q1 25 | $881.5M | $18.6M | ||
| Q4 24 | $863.5M | $3.3M | ||
| Q3 24 | $874.5M | $-14.6M | ||
| Q2 24 | $850.5M | $-29.9M | ||
| Q1 24 | $847.6M | $-31.7M |
总资产HFWARIGL
| Q4 25 | $7.0B | $513.6M | ||
| Q3 25 | $7.0B | $242.5M | ||
| Q2 25 | $7.1B | $206.7M | ||
| Q1 25 | $7.1B | $176.0M | ||
| Q4 24 | $7.1B | $164.0M | ||
| Q3 24 | $7.2B | $139.4M | ||
| Q2 24 | $7.1B | $128.4M | ||
| Q1 24 | $7.1B | $126.5M |
负债/权益比HFWARIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $94.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $85.7M | — |
| 自由现金流率自由现金流/营收 | 129.1% | — |
| 资本支出强度资本支出/营收 | 13.8% | — |
| 现金转化率经营现金流/净利润 | 4.26× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $149.0M | — |
8季度趋势，按日历期对齐
经营现金流HFWARIGL
| Q4 25 | $94.8M | $22.0M | ||
| Q3 25 | $25.1M | $24.0M | ||
| Q2 25 | $22.5M | $30.5M | ||
| Q1 25 | $19.3M | $-893.0K | ||
| Q4 24 | $64.5M | $14.5M | ||
| Q3 24 | $24.2M | $21.7M | ||
| Q2 24 | $6.8M | $302.0K | ||
| Q1 24 | $12.9M | $-5.0M |
自由现金流HFWARIGL
| Q4 25 | $85.7M | — | ||
| Q3 25 | $24.4M | — | ||
| Q2 25 | $20.9M | — | ||
| Q1 25 | $18.1M | — | ||
| Q4 24 | $61.0M | — | ||
| Q3 24 | $23.2M | — | ||
| Q2 24 | $6.0M | — | ||
| Q1 24 | $12.0M | — |
自由现金流率HFWARIGL
| Q4 25 | 129.1% | — | ||
| Q3 25 | 37.1% | — | ||
| Q2 25 | 37.0% | — | ||
| Q1 25 | 31.4% | — | ||
| Q4 24 | 107.0% | — | ||
| Q3 24 | 42.4% | — | ||
| Q2 24 | 10.6% | — | ||
| Q1 24 | 24.7% | — |
资本支出强度HFWARIGL
| Q4 25 | 13.8% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.8% | — |
现金转化率HFWARIGL
| Q4 25 | 4.26× | 0.08× | ||
| Q3 25 | 1.31× | 0.86× | ||
| Q2 25 | 1.84× | 0.51× | ||
| Q1 25 | 1.38× | -0.08× | ||
| Q4 24 | 5.41× | 1.01× | ||
| Q3 24 | 2.12× | 1.75× | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | 2.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
